Amphotericin B-entrapping lipid nanoparticles and their in vitro and in vivo characteristics.
about
An Amphotericin B Derivative Equally Potent to Amphotericin B and with Increased SafetyEnhanced Antifungal Activity by Ab-Modified Amphotericin B-Loaded Nanoparticles Using a pH-Responsive Block CopolymerAntifungal efficacy of itraconazole-loaded TPGS-b-(PCL-ran-PGA) nanoparticles.Enhanced stability and permeation potential of nanoemulsion containing sefsol-218 oil for topical delivery of amphotericin B.Nanomedicine as an emerging approach against intracellular pathogensPreparation and antifungal activity of spray-dried amphotericin B-loaded nanospheres.Gd(III)-DOTA-modified sonosensitive liposomes for ultrasound-triggered release and MR imaging.Novel targeting using nanoparticles: an approach to the development of an effective anti-leishmanial drug-delivery system.Antifungal Therapy for Systemic Mycosis and the Nanobiotechnology Era: Improving Efficacy, Biodistribution and Toxicity.Novel small molecules for the treatment of infections caused by Candida albicans: a patent review (2002-2010).Systemic Antifungal Agents: Current Status and Projected Future Developments.Chitosan-assisted immunotherapy for intervention of experimental leishmaniasis via amphotericin B-loaded solid lipid nanoparticles.Role of protein kinase A signaling pathway in cyclosporine nephrotoxicity.The antifungal pipeline: a reality check.Itraconazole-loaded poly(lactic-co-glycolic) acid nanoparticles for improved antifungal activity.Surface association and uptake of poly(lactic-co-glycolic) acid nanoparticles by Aspergillus flavus.Alteration in cellular viability, pro-inflammatory cytokines and nitric oxide production in nephrotoxicity generation by Amphotericin B: involvement of PKA pathway signaling.Significance of algal polymer in designing amphotericin B nanoparticles.Poly(methacrylic acid) complexation of amphotericin B to treat neglected diseases
P2860
Q28554384-348FEE18-54B5-4E82-9D37-98EAD4F10156Q28647760-F60E03A4-4F98-4D16-A9F7-5170F6F440F6Q35110919-AA9F365B-D280-4B34-B125-CF023A626648Q35127147-8EDE18AB-C89E-4D99-955B-CCC151C4BE61Q35656908-59A6E29D-8DB9-4E05-A648-BA27E52D1745Q35832248-FC411237-BD7B-42F1-9001-21456BBFB3CEQ36465926-FDFCACE1-600C-4972-B1B3-6FF9DB21201CQ37597619-8DBFC9C3-019F-47EE-9B99-2BB8501D7820Q37684378-8EAB8CD8-1FA4-4B38-A12C-76087B63B9CAQ37829442-C857F185-B8F5-4809-8DDB-C661C215F5CBQ38796140-C97FD3F9-1667-46EE-A154-C0CEA4BE411BQ38967744-355E63B2-113C-49DF-94C8-227B8D3C7447Q38999902-6025EBC0-5C20-4D0D-AD58-8DBA6DEB09C6Q39299949-F59796CC-AD76-4C64-B539-2FEBC4287C7EQ42875464-5CB7D94B-5396-4F2E-9947-128EC620C4C0Q50443547-734C499C-B0D9-425A-97A5-5CC851126F3CQ54404471-35F9854B-F475-4F62-A663-825EAD593032Q54917788-46EFA667-CC8B-47B4-A2BD-60C8E6FBF522Q57347954-A0E7321F-BE77-4960-BE5C-70AEA30E7C6C
P2860
Amphotericin B-entrapping lipid nanoparticles and their in vitro and in vivo characteristics.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Amphotericin B-entrapping lipi ...... o and in vivo characteristics.
@en
Amphotericin B-entrapping lipi ...... o and in vivo characteristics.
@nl
type
label
Amphotericin B-entrapping lipi ...... o and in vivo characteristics.
@en
Amphotericin B-entrapping lipi ...... o and in vivo characteristics.
@nl
prefLabel
Amphotericin B-entrapping lipi ...... o and in vivo characteristics.
@en
Amphotericin B-entrapping lipi ...... o and in vivo characteristics.
@nl
P2093
P1476
Amphotericin B-entrapping lipi ...... o and in vivo characteristics.
@en
P2093
Byung Cheol Shin
Deok Hwi Lim
Hasoo Seong
Jung Eun Lee
Kyu-Sung Jeong
Soon Hwa Jung
Suk Hyun Jung
P304
P356
10.1016/J.EJPS.2009.02.021
P407
P577
2009-03-13T00:00:00Z